Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026)
Neogen (NEOG) recorded quarterly Non-Current Deferred Tax Liability of $269.2 million in Q1 2026, down 1.73% quarter-over-quarter from $273.9 million in Q4 2025, and down 10.58% on a YoY basis from $301.1 million in Q1 2025.
Neogen (NEOG) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Neogen's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $269.2 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 10.58% year-over-year to $269.2 million; the TTM figure through Feb 2026 stood at $269.2 million (down 10.58% YoY), while the FY2025 annual figure was $280.9 million, down 14.02% from the prior year.
- Non-Current Deferred Tax Liability was $269.2 million for Q1 2026 at Neogen, down from $273.9 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $364.3 million in Q4 2022 to a low of $15.9 million in Q3 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $267.5 million across 5 years, with a median of $302.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability tumbled 34.59% in 2022, then soared 2124.54% in 2023.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $364.3 million in 2022, then declined by 2.54% to $355.0 million in 2023, then retreated by 14.82% to $302.4 million in 2024, then slipped by 9.41% to $273.9 million in 2025, then retreated by 1.73% to $269.2 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $269.2 million (Q1 2026), $273.9 million (Q4 2025), and $277.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 269.20 Mn |
| Feb 28, 2026 | 269.20 Mn |
| Nov 30, 2025 | 273.95 Mn |
| Nov 30, 2025 | 273.95 Mn |
| Aug 31, 2025 | 277.25 Mn |
| Aug 31, 2025 | 277.25 Mn |
| May 31, 2025 | 280.90 Mn |
| May 31, 2025 | 280.90 Mn |
| Feb 28, 2025 | 301.05 Mn |
| Feb 28, 2025 | 301.05 Mn |
| Nov 30, 2024 | 302.41 Mn |
| Nov 30, 2024 | 302.41 Mn |
| Aug 31, 2024 | 317.57 Mn |
| Aug 31, 2024 | 317.57 Mn |
| May 31, 2024 | 326.72 Mn |
| May 31, 2024 | 326.72 Mn |
| Feb 29, 2024 | 353.85 Mn |
| Feb 29, 2024 | 353.85 Mn |
| Nov 30, 2023 | 355.01 Mn |
| Nov 30, 2023 | 355.01 Mn |